Sollievo Pharmaceuticals, Inc.
Based in San Juan Capistrano, CA, Sollievo Pharmaceuticals, Inc. is a startup pharmaceutical company that is positioned to disrupt the $500 million global injectable (parenteral) benzodiazepine market. Benzodiazepines, which are used to relax and sedate patients, were developed between 1960 and 1990, but little innovation has taken place since then. Sollievo is well positioned to disrupt this market, with the first introduction of a novel injectable benzodiazepine in more than 30 years!
We have developed a diazepam pro-drug that has demonstrated a 75% faster onset of action.
The onset of action of our pro-drug is ideal for acute agitation and aggression in emergency patients.
Our sedative in injectable form is the first major advancement in more than three decades.
Quick and predictable sedation can improve safety for both healthcare workers and the patients.
If you’re interested in receiving more information, or have any other questions,
please give us a call!